Concepedia

Chaowei Ren

CR

8

Publications

437

Citations

8

H-Index

2019

Active since

Affiliations

ShanghaiTech University(Current)

Shanghai Institute of Organic Chemistry

Chinese Academy of Sciences

University of Chinese Academy of Sciences

Anhui Medical University

Chaowei Ren is an author at ShanghaiTech University specializing in medicine, biochemistry, and drug discovery.

Top concepts

Publications per year

2019–2022

8

Publications

8

Discovery of SIAIS178 as an Effective BCR-ABL Degrader by Recruiting Von Hippel–Lindau (VHL) E3 Ubiquitin Ligase

Quanju Zhao, Chaowei Ren, Linyi Liu et al. · Journal of Medicinal Chemistry · 2019 · 121 citations

Development of a Brigatinib degrader (SIAIS117) as a potential treatment for ALK positive cancer resistance

Ning Sun, Chaowei Ren, Ying Kong et al. · European Journal of Medicinal Chemistry · 2020 · 72 citations · Full text

, , +6

Reactive oxygen species-responsive Pre-PROTAC for tumor-specific protein degradation

Haixia Liu, Chaowei Ren, Renhong Sun et al. · Chemical Communications · 2022 · 58 citations

Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluation

Haixia Liu, Xinyu Ding, Linyi Liu et al. · European Journal of Medicinal Chemistry · 2021 · 50 citations

, , +5

Structure-based discovery of SIAIS001 as an oral bioavailability ALK degrader constructed from Alectinib

Chaowei Ren, Ning Sun, Ying Kong et al. · European Journal of Medicinal Chemistry · 2021 · 43 citations · Full text

, , +6

Rows per page

1–5 of 8